Cargando…

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Du, Quan, Thonberg, Håkan, Wang, Jue, Wahlestedt, Claes, Liang, Zicai
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2005
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1166582/ http://dx.doi.org/10.1093/nar/gki647

Ejemplares similares

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

Analysis of siRNA specificity on targets with double-nucleotide mismatches
por: Dahlgren, Cecilia, et al.
Publicado: (2008)

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
por: Elmén, Joacim, et al.
Publicado: (2005)

siRNA Has Greatly Elevated Mismatch Tolerance at 3′-UTR Sites
por: Wei, Na, et al.
Publicado: (2012)

Vector-based siRNA delivery strategies for high-throughput screening of novel target genes
por: Chen, Meihong, et al.
Publicado: (2005)

Enhancement of Allele Discrimination by Introduction of Nucleotide Mismatches into siRNA in Allele-Specific Gene Silencing by RNAi
por: Ohnishi, Yusuke, et al.
Publicado: (2008)

siRNAdb: a database of siRNA sequences
por: Chalk, Alistair M., et al.
Publicado: (2005)

Differences in silencing of mismatched targets by sliced versus diced siRNAs
por: Sun, Guihua, et al.
Publicado: (2018)

Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs
por: Huang, Huang, et al.
Publicado: (2009)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

Designing of Highly Effective Complementary and Mismatch siRNAs for Silencing a Gene
por: Ahmed, Firoz, et al.
Publicado: (2011)

Identification of metabolically stable 5΄-phosphate analogs that support single-stranded siRNA activity
por: Prakash, Thazha P., et al.
Publicado: (2017)

SiRNA-mediated PIAS1 silencing promotes inflammatory response and leads to injury of cerulein-stimulated pancreatic acinar cells via regulation of the P38MAPK signaling pathway
por: Chen, Ping, et al.
Publicado: (2021)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
por: Lin, Guimiao, et al.
Publicado: (2017)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

Site-Specific Modification Using the 2′-Methoxyethyl Group Improves the Specificity and Activity of siRNAs
por: Song, Xinyun, et al.
Publicado: (2017)

Inter-molecular β-sheet structure facilitates lung-targeting siRNA delivery
por: Zhou, Jihan, et al.
Publicado: (2016)

Therapeutic siRNA silencing in inflammatory monocytes
por: Leuschner, Florian, et al.
Publicado: (2011)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

siRNA-mediated inhibition of endogenous brain-derived neurotrophic factor gene modulates the biological behavior of HeLa cells
por: Sun, Chun-Yan, et al.
Publicado: (2021)

An Attempt to Detect siRNA-Mediated Genomic DNA Modification by Artificially Induced Mismatch siRNA in Arabidopsis
por: Miyagawa, Yosuke, et al.
Publicado: (2013)

Single-nucleotide-resolution mapping of DNA gyrase cleavage sites across the Escherichia coli genome
por: Sutormin, Dmitry, et al.
Publicado: (2019)

High potency silencing by single-stranded boranophosphate siRNA
por: Hall, Allison H. S., et al.
Publicado: (2006)

Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015)

Improved siRNA/shRNA Functionality by Mismatched Duplex
por: Wu, Haoquan, et al.
Publicado: (2011)

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
Publicado: (2021)

Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)

The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing
por: Stalder, Lukas, et al.
Publicado: (2013)

Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations
por: Dudhal, Swati, et al.
Publicado: (2022)

Corrigendum to “Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor” [Data Brief 3 (2015) 117–119]
por: Brioschi, Maura, et al.
Publicado: (2015)

Corrigendum to: iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
Publicado: (2022)

Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene-silencing effects and siRNA biodistribution in mice
por: Hattori, Yoshiyuki, et al.
Publicado: (2020)

In vivo silencing of alpha-synuclein using naked siRNA
por: Lewis, Jada, et al.
Publicado: (2008)

Primary and Secondary siRNAs in Geminivirus-induced Gene Silencing
por: Aregger, Michael, et al.
Publicado: (2012)

Chitosan Hydrogel as siRNA vector for prolonged gene silencing
por: Ma, Zhiwei, et al.
Publicado: (2014)

siRNA Versus miRNA as Therapeutics for Gene Silencing
por: Lam, Jenny K W, et al.
Publicado: (2015)

Strategies for Improving siRNA-Induced Gene Silencing Efficiency
por: Safari, Fatemeh, et al.
Publicado: (2017)

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9dna32svkacl7lhcvlrljbvm3u